Methylated cis-regulatory elements mediate KLF4-denpendent gene transactivation and cell migration

  1. Jun Wan
  2. Yijing Su
  3. Qifeng Song
  4. Brian Tung
  5. Olutobi Oyinlade
  6. Sheng Liu
  7. Mingyao Ying
  8. Guo-li Ming
  9. Hongjun Song
  10. Jiang Qian  Is a corresponding author
  11. Heng Zhu  Is a corresponding author
  12. Shuli Xia  Is a corresponding author
  1. Indiana University School of Medicine, United States
  2. Johns Hopkins University School of Medicine, United States

Abstract

Altered DNA methylation status is associated with human diseases and cancer; however, the underlying molecular mechanisms remain elusive. We previously identified many human transcription factors, including Krüppel-like factor 4 (KLF4), as sequence-specific DNA methylation readers that preferentially recognize methylated CpG (mCpG), here we report the biological function of mCpG-dependent gene regulation by KLF4 in glioblastoma cells. We show that KLF4 promotes cell adhesion, migration, and morphological changes, all of which are abolished by R458A mutation. Surprisingly, 116 genes are directly activated via mCpG-dependent KLF4 binding activity. In-depth mechanistic studies reveal that recruitment of KLF4 to the methylated cis-regulatory elements of these genes result in chromatin remodeling and transcription activation. Our study demonstrates a new paradigm of DNA methylation-mediated gene activation and chromatin remodeling, and provides a general framework to dissect the biological functions of DNA methylation readers and effectors.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Jun Wan

    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Yijing Su

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Qifeng Song

    Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Brian Tung

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Olutobi Oyinlade

    Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Sheng Liu

    The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Mingyao Ying

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Guo-li Ming

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Hongjun Song

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Jiang Qian

    The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, United States
    For correspondence
    jiang.qian@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
  11. Heng Zhu

    Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States
    For correspondence
    hzhu4@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
  12. Shuli Xia

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States
    For correspondence
    xia@kennedykrieger.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5849-6967

Funding

National Institutes of Health (R01NS091165)

  • Shuli Xia

National Institutes of Health (EY024580)

  • Jiang Qian

National Institutes of Health (R01 GM111514)

  • Heng Zhu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Bing Ren, University of California, San Diego School of Medicine, United States

Version history

  1. Received: August 20, 2016
  2. Accepted: May 24, 2017
  3. Accepted Manuscript published: May 29, 2017 (version 1)
  4. Version of Record published: June 9, 2017 (version 2)

Copyright

© 2017, Wan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,967
    views
  • 370
    downloads
  • 36
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jun Wan
  2. Yijing Su
  3. Qifeng Song
  4. Brian Tung
  5. Olutobi Oyinlade
  6. Sheng Liu
  7. Mingyao Ying
  8. Guo-li Ming
  9. Hongjun Song
  10. Jiang Qian
  11. Heng Zhu
  12. Shuli Xia
(2017)
Methylated cis-regulatory elements mediate KLF4-denpendent gene transactivation and cell migration
eLife 6:e20068.
https://doi.org/10.7554/eLife.20068

Share this article

https://doi.org/10.7554/eLife.20068

Further reading

    1. Cell Biology
    Yoko Nakai-Futatsugi, Jianshi Jin ... Masayo Takahashi
    Research Article

    Retinal pigment epithelium (RPE) cells show heterogeneous levels of pigmentation when cultured in vitro. To know whether their color in appearance is correlated with the function of the RPE, we analyzed the color intensities of human-induced pluripotent stem cell-derived RPE cells (iPSC-RPE) together with the gene expression profile at the single-cell level. For this purpose, we utilized our recent invention, Automated Live imaging and cell Picking System (ALPS), which enabled photographing each cell before RNA-sequencing analysis to profile the gene expression of each cell. While our iPSC-RPE were categorized into four clusters by gene expression, the color intensity of iPSC-RPE did not project any specific gene expression profiles. We reasoned this by less correlation between the actual color and the gene expressions that directly define the level of pigmentation, from which we hypothesized the color of RPE cells may be a temporal condition not strongly indicating the functional characteristics of the RPE.

    1. Cancer Biology
    2. Cell Biology
    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signaling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor-1. Overall, we implicate CYRI-B as a mediator of growth and signaling in pancreatic cancer, providing new insights into pathways controlling metastasis.